Searched for
FOOD AND DRUG ADMINISTRATION
No raids till further orders: Maharashtra tells Bombay HC in Patanjali labelling caseThe Maharashtra government has assured the Bombay High Court it will halt raids and confiscations concerning ayurvedic product labels. This...- Concord Biotech shares gain 6% after USFDA approval for Tofacitinib tabletsConcord Biotech's shares surged over 6% after receiving USFDA approval for its Tofacitinib Tablets in 5 mg and 10 mg strengths. This approv...
- How to remove pesticides naturally from your favourite summer fruits: Berries, peaches and plumsSummer's bounty of berries, peaches, and plums offers peak flavour and nutrition. While delicious, these fruits can carry pesticide residue...
- $10. 6 billion deal: GSK to buy US cancer specialist NuvalentBritish pharmaceutical giant GSK has announced a massive $10.6 billion deal to acquire Nuvalent. This Boston-based company specializes in c...
- 20,000 kg sugar-mixed jaggery, coloured peas seized in Pune food safety department raidsThe FDA in Pune seized 16 tonnes of jaggery and 20 tonnes of sugar intended for adulteration, alongside 68 kg of artificially coloured frie...
- In 1937, a chemistry student tasted something sweet on a cigarette, and this led to a sweetener that changed diet foods industryA lab accident in 1937 led to the discovery of cyclamate, an artificial sweetener. It quickly became popular for low-calorie products. Late...
- Concord Biotech shares jump 8% on USFDA nod for Mycophenolate Mofetil oral suspensionConcord Biotech shares saw a significant jump on Wednesday. This surge followed the company's announcement of receiving approval from the U...
- US stocks: Fulcrum shares plummet over 50% after scrapping lead sickle-cell drug on FDA concernsThe oral drug, pociredir, was being tested to treat sickle-cell disease, an inherited blood disorder that can trigger pain, anemia and or...
- Wockhardt shares pause massive 36% rally in 5 sessions; slip 7%. What’s behind the selloff?Wockhardt shares dropped after a recent surge, as investors took profits. This followed the US FDA approval of ZAYNICH, an antibiotic for u...
- Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check detailsWockhardt's shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections....
- Wockhardt secures US FDA approval for antibiotic ZaynichWockhardt's novel antibiotic, Zaynich (cefepime and zidebactam), has received US FDA approval for complicated urinary tract infections. Thi...
- Pune hooch tragedy: Toll rises to 17 as 22 police, excise officials suspended, methanol supplier tracedA spurious liquor tragedy in Pune and Pimpri Chinchwad has claimed 17 to 18 lives. Most victims were daily wage labourers. The state govern...
- $994 SSI check update: Will millions get paid on June 1 or face a surprise delay? June 2026 Social Security Schedule ExplainedMillions of SSI recipients are set to receive their $994 SSI check on June 1, 2026, according to the Social Security Administration's payme...
- U.S. drug regulator flags data integrity, maintenance lapses at Dabur India plantThe U.S. FDA has identified significant data integrity and manufacturing lapses at a Dabur India plant following a January inspection. Find...
- Bio Medica Laboratories shares to debut today. Here's what GMP suggests ahead of listingBio Medica Laboratories' shares are set to list on the NSE SME platform amidst weak grey market sentiment, with the IPO currently trading a...
- Stocks in news: RIL, Coal India, IDFC First Bank, Zydus Life, ONGCMarkets traded subdued with the India VIX correcting nearly 15% this week, though this hasn't significantly impacted benchmark index moveme...
- Zydus Therapeutics' saroglitazar drug granted priority review by US FDAZydus Therapeutics' drug saroglitazar has received priority review from the US FDA. This drug treats primary biliary cholangitis, a liver d...
- Gene therapy for cholesterol: Initial test results cheerA new gene editing medicine, VERVE-102, offers hope for millions with heart conditions. Eli Lilly's drug showed significant reductions in b...
- An SNL 'All Drug Olympics?' Not quite. But these Enhanced Games are no jokeThe "Enhanced Games" in Las Vegas allows athletes to use performance enhancers, aiming to challenge mainstream sports' anti-doping efforts ...
- Pregabalin moved to Schedule H1 as centre cracks down on drug misusePregabalin, a nerve pain medication, now faces stricter controls. The Union health ministry has moved it to Schedule H1. This change aims t...
Load More
